EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence

Tuan Vu, Heinz Wiendl, Masahisa Katsuno, Stephen W Reddel, James F Howard

Neuropsychiatric Disease and Treatment · 2023-12 · Volume 19 · 2639-2655

DOI: 10.2147/ndt.s374694 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuropsychiatric Disease and Treatment, 2023-12. Verfasst von Tuan Vu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

acetylcholine receptor antibodycomplementmembrane attack complexmonoclonal antibodyterminal complement complex

Autor:innen und Institutionen

  • Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
  • Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Neurology, Concord Hospital, University of Sydney, Sydney, NSW, Australia.
  • Department of Neurology, The University of North Carolina, Chapel Hill, NC, USA.

Zitieren

APA

Vu, T., Wiendl, H., Katsuno, M., Reddel, S. W., & Howard, J. F. (2023). Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence. Neuropsychiatric Disease and Treatment, Volume 19, 2639-2655. https://doi.org/10.2147/ndt.s374694

Vancouver

Vu T, Wiendl H, Katsuno M, Reddel SW, Howard JF. Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence. Neuropsychiatric Disease and Treatment. 2023;Volume 19:2639-2655. doi:10.2147/ndt.s374694

BibTeX
@article{Vu2023,
  author = {Vu, Tuan and Wiendl, Heinz and Katsuno, Masahisa and Reddel, Stephen W and Howard, James F},
  title = {Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence},
  journal = {Neuropsychiatric Disease and Treatment},
  year = {2023},
  volume = {Volume 19},
  pages = {2639--2655},
  doi = {10.2147/ndt.s374694}
}
Kostenlos starten →